Northland Capital Markets Initiates Coverage On AVITA Medical with Outperform Rating, Announces Price Target of $10
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Northland Capital Markets analyst Carl Byrnes initiates coverage on AVITA Medical (NASDAQ:RCEL) with a Outperform rating and announces Price Target of $10.
Northland Capital Markets analyst Carl Byrnes initiates coverage on AVITA Medical (NASDAQ:RCEL) with a Outperform rating and announces Price Target of $10.